[
    [
        {
            "time": "",
            "original_text": "欧普康视(300595.SZ)全资子公司欧普投资拟以5828.57万元投资苏州康视",
            "features": {
                "keywords": [
                    "欧普康视",
                    "全资子公司",
                    "欧普投资",
                    "苏州康视",
                    "投资"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "欧普康视(300595.SZ)全资子公司欧普投资拟以5828.57万元投资苏州康视",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "欧普康视(300595.SZ)股东欧普民生质押350万股并解除质押415.5万股",
            "features": {
                "keywords": [
                    "欧普康视",
                    "欧普民生",
                    "质押",
                    "解除质押"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "欧普康视(300595.SZ)股东欧普民生质押350万股并解除质押415.5万股",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业周报：三季报密集披露 浙江率先公布新冠疫苗价格",
            "features": {
                "keywords": [
                    "医药生物",
                    "三季报",
                    "新冠疫苗",
                    "浙江"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报：三季报密集披露 浙江率先公布新冠疫苗价格",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业跨市场周报：冠脉支架全国集采政策落地 未来或催生两大高耗投资方向",
            "features": {
                "keywords": [
                    "医药生物",
                    "冠脉支架",
                    "集采政策",
                    "高耗投资"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业跨市场周报：冠脉支架全国集采政策落地 未来或催生两大高耗投资方向",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "创业板指跌幅扩大至1%，乐普医疗、贝达药业、欧普康视、康龙化成领跌",
            "features": {
                "keywords": [
                    "创业板指",
                    "跌幅",
                    "乐普医疗",
                    "贝达药业",
                    "欧普康视",
                    "康龙化成"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "创业板指跌幅扩大至1%，乐普医疗、贝达药业、欧普康视、康龙化成领跌",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "医疗行业反腐利剑出鞘！揭开巨额销售费用“画皮”",
            "features": {
                "keywords": [
                    "医疗行业",
                    "反腐",
                    "销售费用"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医疗行业反腐利剑出鞘！揭开巨额销售费用“画皮”",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]